img

Global Peptides Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Peptides Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Peptides market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Peptides is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Peptides is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Peptides is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Peptides include Cipla Ltd., Emcure Pharmaceuticals Pvt. Ltd., Gland Pharma Limited, Troikaa Pharmaceuticals Ltd., Biological E Limited, Bharat Biotech, Samarth Life Sciences Pvt. Ltd., VHB Life Sciences Limited and Celon Laboratories Pvt. Ltd., etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Peptides, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Peptides by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Peptides market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Peptides market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Cipla Ltd.
Emcure Pharmaceuticals Pvt. Ltd.
Gland Pharma Limited
Troikaa Pharmaceuticals Ltd.
Biological E Limited
Bharat Biotech
Samarth Life Sciences Pvt. Ltd.
VHB Life Sciences Limited
Celon Laboratories Pvt. Ltd.
United Biotech(P) Limited
By Type
Insulin
Teriparatide
Liraglutide
Leuprolide
By Application
Diabetes
Infectious Diseases
Cancer
Osteoporosis
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Peptides in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Peptides manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peptides sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Peptides Definition
1.2 Market by Type
1.2.1 Global Peptides Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Insulin
1.2.3 Teriparatide
1.2.4 Liraglutide
1.2.5 Leuprolide
1.3 Market Segment by Application
1.3.1 Global Peptides Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Diabetes
1.3.3 Infectious Diseases
1.3.4 Cancer
1.3.5 Osteoporosis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Peptides Sales
2.1 Global Peptides Revenue Estimates and Forecasts 2018-2034
2.2 Global Peptides Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Peptides Revenue by Region
2.3.1 Global Peptides Revenue by Region (2018-2024)
2.3.2 Global Peptides Revenue by Region (2024-2034)
2.4 Global Peptides Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Peptides Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Peptides Sales Quantity by Region
2.6.1 Global Peptides Sales Quantity by Region (2018-2024)
2.6.2 Global Peptides Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Peptides Sales Quantity by Manufacturers
3.1.1 Global Peptides Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Peptides Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Peptides Sales in 2022
3.2 Global Peptides Revenue by Manufacturers
3.2.1 Global Peptides Revenue by Manufacturers (2018-2024)
3.2.2 Global Peptides Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Peptides Revenue in 2022
3.3 Global Peptides Sales Price by Manufacturers
3.4 Global Key Players of Peptides, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Peptides, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Peptides, Product Offered and Application
3.8 Global Key Manufacturers of Peptides, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Peptides Sales Quantity by Type
4.1.1 Global Peptides Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Peptides Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Peptides Sales Quantity Market Share by Type (2018-2034)
4.2 Global Peptides Revenue by Type
4.2.1 Global Peptides Historical Revenue by Type (2018-2024)
4.2.2 Global Peptides Forecasted Revenue by Type (2024-2034)
4.2.3 Global Peptides Revenue Market Share by Type (2018-2034)
4.3 Global Peptides Price by Type
4.3.1 Global Peptides Price by Type (2018-2024)
4.3.2 Global Peptides Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Peptides Sales Quantity by Application
5.1.1 Global Peptides Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Peptides Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Peptides Sales Quantity Market Share by Application (2018-2034)
5.2 Global Peptides Revenue by Application
5.2.1 Global Peptides Historical Revenue by Application (2018-2024)
5.2.2 Global Peptides Forecasted Revenue by Application (2024-2034)
5.2.3 Global Peptides Revenue Market Share by Application (2018-2034)
5.3 Global Peptides Price by Application
5.3.1 Global Peptides Price by Application (2018-2024)
5.3.2 Global Peptides Price Forecast by Application (2024-2034)
6 North America
6.1 North America Peptides Sales by Company
6.1.1 North America Peptides Revenue by Company (2018-2024)
6.1.2 North America Peptides Sales Quantity by Company (2018-2024)
6.2 North America Peptides Market Size by Type
6.2.1 North America Peptides Sales Quantity by Type (2018-2034)
6.2.2 North America Peptides Revenue by Type (2018-2034)
6.3 North America Peptides Market Size by Application
6.3.1 North America Peptides Sales Quantity by Application (2018-2034)
6.3.2 North America Peptides Revenue by Application (2018-2034)
6.4 North America Peptides Market Size by Country
6.4.1 North America Peptides Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Peptides Revenue by Country (2018-2034)
6.4.3 North America Peptides Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Peptides Sales by Company
7.1.1 Europe Peptides Sales Quantity by Company (2018-2024)
7.1.2 Europe Peptides Revenue by Company (2018-2024)
7.2 Europe Peptides Market Size by Type
7.2.1 Europe Peptides Sales Quantity by Type (2018-2034)
7.2.2 Europe Peptides Revenue by Type (2018-2034)
7.3 Europe Peptides Market Size by Application
7.3.1 Europe Peptides Sales Quantity by Application (2018-2034)
7.3.2 Europe Peptides Revenue by Application (2018-2034)
7.4 Europe Peptides Market Size by Country
7.4.1 Europe Peptides Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Peptides Revenue by Country (2018-2034)
7.4.3 Europe Peptides Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Peptides Sales by Company
8.1.1 China Peptides Sales Quantity by Company (2018-2024)
8.1.2 China Peptides Revenue by Company (2018-2024)
8.2 China Peptides Market Size by Type
8.2.1 China Peptides Sales Quantity by Type (2018-2034)
8.2.2 China Peptides Revenue by Type (2018-2034)
8.3 China Peptides Market Size by Application
8.3.1 China Peptides Sales Quantity by Application (2018-2034)
8.3.2 China Peptides Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Peptides Sales by Company
9.1.1 APAC Peptides Sales Quantity by Company (2018-2024)
9.1.2 APAC Peptides Revenue by Company (2018-2024)
9.2 APAC Peptides Market Size by Type
9.2.1 APAC Peptides Sales Quantity by Type (2018-2034)
9.2.2 APAC Peptides Revenue by Type (2018-2034)
9.3 APAC Peptides Market Size by Application
9.3.1 APAC Peptides Sales Quantity by Application (2018-2034)
9.3.2 APAC Peptides Revenue by Application (2018-2034)
9.4 APAC Peptides Market Size by Region
9.4.1 APAC Peptides Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Peptides Revenue by Region (2018-2034)
9.4.3 APAC Peptides Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Peptides Sales by Company
10.1.1 Middle East, Africa and Latin America Peptides Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Peptides Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Peptides Market Size by Type
10.2.1 Middle East, Africa and Latin America Peptides Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Peptides Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Peptides Market Size by Application
10.3.1 Middle East, Africa and Latin America Peptides Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Peptides Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Peptides Market Size by Country
10.4.1 Middle East, Africa and Latin America Peptides Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Peptides Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Peptides Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Cipla Ltd.
11.1.1 Cipla Ltd. Company Information
11.1.2 Cipla Ltd. Overview
11.1.3 Cipla Ltd. Peptides Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Cipla Ltd. Peptides Products and Services
11.1.5 Cipla Ltd. Peptides SWOT Analysis
11.1.6 Cipla Ltd. Recent Developments
11.2 Emcure Pharmaceuticals Pvt. Ltd.
11.2.1 Emcure Pharmaceuticals Pvt. Ltd. Company Information
11.2.2 Emcure Pharmaceuticals Pvt. Ltd. Overview
11.2.3 Emcure Pharmaceuticals Pvt. Ltd. Peptides Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Emcure Pharmaceuticals Pvt. Ltd. Peptides Products and Services
11.2.5 Emcure Pharmaceuticals Pvt. Ltd. Peptides SWOT Analysis
11.2.6 Emcure Pharmaceuticals Pvt. Ltd. Recent Developments
11.3 Gland Pharma Limited
11.3.1 Gland Pharma Limited Company Information
11.3.2 Gland Pharma Limited Overview
11.3.3 Gland Pharma Limited Peptides Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Gland Pharma Limited Peptides Products and Services
11.3.5 Gland Pharma Limited Peptides SWOT Analysis
11.3.6 Gland Pharma Limited Recent Developments
11.4 Troikaa Pharmaceuticals Ltd.
11.4.1 Troikaa Pharmaceuticals Ltd. Company Information
11.4.2 Troikaa Pharmaceuticals Ltd. Overview
11.4.3 Troikaa Pharmaceuticals Ltd. Peptides Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Troikaa Pharmaceuticals Ltd. Peptides Products and Services
11.4.5 Troikaa Pharmaceuticals Ltd. Peptides SWOT Analysis
11.4.6 Troikaa Pharmaceuticals Ltd. Recent Developments
11.5 Biological E Limited
11.5.1 Biological E Limited Company Information
11.5.2 Biological E Limited Overview
11.5.3 Biological E Limited Peptides Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Biological E Limited Peptides Products and Services
11.5.5 Biological E Limited Peptides SWOT Analysis
11.5.6 Biological E Limited Recent Developments
11.6 Bharat Biotech
11.6.1 Bharat Biotech Company Information
11.6.2 Bharat Biotech Overview
11.6.3 Bharat Biotech Peptides Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Bharat Biotech Peptides Products and Services
11.6.5 Bharat Biotech Peptides SWOT Analysis
11.6.6 Bharat Biotech Recent Developments
11.7 Samarth Life Sciences Pvt. Ltd.
11.7.1 Samarth Life Sciences Pvt. Ltd. Company Information
11.7.2 Samarth Life Sciences Pvt. Ltd. Overview
11.7.3 Samarth Life Sciences Pvt. Ltd. Peptides Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Samarth Life Sciences Pvt. Ltd. Peptides Products and Services
11.7.5 Samarth Life Sciences Pvt. Ltd. Peptides SWOT Analysis
11.7.6 Samarth Life Sciences Pvt. Ltd. Recent Developments
11.8 VHB Life Sciences Limited
11.8.1 VHB Life Sciences Limited Company Information
11.8.2 VHB Life Sciences Limited Overview
11.8.3 VHB Life Sciences Limited Peptides Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 VHB Life Sciences Limited Peptides Products and Services
11.8.5 VHB Life Sciences Limited Peptides SWOT Analysis
11.8.6 VHB Life Sciences Limited Recent Developments
11.9 Celon Laboratories Pvt. Ltd.
11.9.1 Celon Laboratories Pvt. Ltd. Company Information
11.9.2 Celon Laboratories Pvt. Ltd. Overview
11.9.3 Celon Laboratories Pvt. Ltd. Peptides Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Celon Laboratories Pvt. Ltd. Peptides Products and Services
11.9.5 Celon Laboratories Pvt. Ltd. Peptides SWOT Analysis
11.9.6 Celon Laboratories Pvt. Ltd. Recent Developments
11.10 United Biotech(P) Limited
11.10.1 United Biotech(P) Limited Company Information
11.10.2 United Biotech(P) Limited Overview
11.10.3 United Biotech(P) Limited Peptides Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 United Biotech(P) Limited Peptides Products and Services
11.10.5 United Biotech(P) Limited Peptides SWOT Analysis
11.10.6 United Biotech(P) Limited Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Peptides Value Chain Analysis
12.2 Peptides Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Peptides Production Mode & Process
12.4 Peptides Sales and Marketing
12.4.1 Peptides Sales Channels
12.4.2 Peptides Distributors
12.5 Peptides Customers
13 Market Dynamics
13.1 Peptides Industry Trends
13.2 Peptides Market Drivers
13.3 Peptides Market Challenges
13.4 Peptides Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Peptides Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Insulin
Table 3. Major Manufacturers of Teriparatide
Table 4. Major Manufacturers of Liraglutide
Table 5. Major Manufacturers of Leuprolide
Table 6. Global Peptides Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Peptides Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Peptides Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Peptides Revenue Market Share by Region (2018-2024)
Table 10. Global Peptides Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Peptides Revenue Market Share by Region (2024-2034)
Table 12. Global Peptides Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Pcs)
Table 13. Global Peptides Sales by Region (2018-2024) & (K Pcs)
Table 14. Global Peptides Sales Market Share by Region (2018-2024)
Table 15. Global Peptides Sales by Region (2024-2034) & (K Pcs)
Table 16. Global Peptides Sales Market Share by Region (2024-2034)
Table 17. Global Peptides Sales Quantity by Manufacturers (2018-2024) & (K Pcs)
Table 18. Global Peptides Sales Quantity Share by Manufacturers (2018-2024)
Table 19. Global Peptides Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Peptides Revenue Share by Manufacturers (2018-2024)
Table 21. Global Peptides Price by Manufacturers 2018-2024 (USD/Pcs)
Table 22. Global Key Players of Peptides, Industry Ranking, 2021 VS 2022
Table 23. Global Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Peptides by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptides as of 2022)
Table 25. Global Key Manufacturers of Peptides, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Peptides, Product Offered and Application
Table 27. Global Key Manufacturers of Peptides, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Peptides Sales Quantity by Type (2018-2024) & (K Pcs)
Table 30. Global Peptides Sales Quantity by Type (2024-2034) & (K Pcs)
Table 31. Global Peptides Sales Quantity Share by Type (2018-2024)
Table 32. Global Peptides Sales Quantity Share by Type (2024-2034)
Table 33. Global Peptides Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Peptides Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Peptides Revenue Share by Type (2018-2024)
Table 36. Global Peptides Revenue Share by Type (2024-2034)
Table 37. Peptides Price by Type (2018-2024) & (USD/Pcs)
Table 38. Global Peptides Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 39. Global Peptides Sales Quantity by Application (2018-2024) & (K Pcs)
Table 40. Global Peptides Sales Quantity by Application (2024-2034) & (K Pcs)
Table 41. Global Peptides Sales Quantity Share by Application (2018-2024)
Table 42. Global Peptides Sales Quantity Share by Application (2024-2034)
Table 43. Global Peptides Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Peptides Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Peptides Revenue Share by Application (2018-2024)
Table 46. Global Peptides Revenue Share by Application (2024-2034)
Table 47. Peptides Price by Application (2018-2024) & (USD/Pcs)
Table 48. Global Peptides Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 49. North America Peptides Revenue by Company (2018-2024) & (US$ Million)
Table 50. North America Peptides Sales Quantity by Company (2018-2024) & (K Pcs)
Table 51. North America Peptides Sales Quantity by Type (2018-2024) & (K Pcs)
Table 52. North America Peptides Sales Quantity by Type (2024-2034) & (K Pcs)
Table 53. North America Peptides Revenue by Type (2018-2024) & (US$ Million)
Table 54. North America Peptides Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Peptides Sales Quantity by Application (2018-2024) & (K Pcs)
Table 56. North America Peptides Sales Quantity by Application (2024-2034) & (K Pcs)
Table 57. North America Peptides Revenue by Application (2018-2024) & (US$ Million)
Table 58. North America Peptides Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Peptides Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 60. North America Peptides Revenue by Country (2018-2024) & (US$ Million)
Table 61. North America Peptides Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Peptides Sales Quantity by Country (2018-2024) & (K Pcs)
Table 63. North America Peptides Sales Quantity by Country (2024-2034) & (K Pcs)
Table 64. Europe Peptides Sales Quantity by Company (2018-2024) & (K Pcs)
Table 65. Europe Peptides Revenue by Company (2018-2024) & (US$ Million)
Table 66. Europe Peptides Sales Quantity by Type (2018-2024) & (K Pcs)
Table 67. Europe Peptides Sales Quantity by Type (2024-2034) & (K Pcs)
Table 68. Europe Peptides Revenue by Type (2018-2024) & (US$ Million)
Table 69. Europe Peptides Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Peptides Sales Quantity by Application (2018-2024) & (K Pcs)
Table 71. Europe Peptides Sales Quantity by Application (2024-2034) & (K Pcs)
Table 72. Europe Peptides Revenue by Application (2018-2024) & (US$ Million)
Table 73. Europe Peptides Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Peptides Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 75. Europe Peptides Revenue by Country (2018-2024) & (US$ Million)
Table 76. Europe Peptides Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Peptides Sales Quantity by Country (2018-2024) & (K Pcs)
Table 78. Europe Peptides Sales Quantity by Country (2024-2034) & (K Pcs)
Table 79. China Peptides Sales Quantity by Company (2018-2024) & (K Pcs)
Table 80. China Peptides Revenue by Company (2018-2024) & (US$ Million)
Table 81. China Peptides Sales Quantity by Type (2018-2024) & (K Pcs)
Table 82. China Peptides Sales Quantity by Type (2024-2034) & (K Pcs)
Table 83. China Peptides Revenue by Type (2018-2024) & (US$ Million)
Table 84. China Peptides Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Peptides Sales Quantity by Application (2018-2024) & (K Pcs)
Table 86. China Peptides Sales Quantity by Application (2024-2034) & (K Pcs)
Table 87. China Peptides Revenue by Application (2018-2024) & (US$ Million)
Table 88. China Peptides Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Peptides Sales Quantity by Company (2018-2024) & (K Pcs)
Table 90. APAC Peptides Revenue by Company (2018-2024) & (US$ Million)
Table 91. APAC Peptides Sales Quantity by Type (2018-2024) & (K Pcs)
Table 92. APAC Peptides Sales Quantity by Type (2024-2034) & (K Pcs)
Table 93. APAC Peptides Revenue by Type (2018-2024) & (US$ Million)
Table 94. APAC Peptides Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Peptides Sales Quantity by Application (2018-2024) & (K Pcs)
Table 96. APAC Peptides Sales Quantity by Application (2024-2034) & (K Pcs)
Table 97. APAC Peptides Revenue by Application (2018-2024) & (US$ Million)
Table 98. APAC Peptides Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Peptides Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 100. APAC Peptides Revenue by Region (2018-2024) & (US$ Million)
Table 101. APAC Peptides Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Peptides Sales Quantity by Region (2018-2024) & (K Pcs)
Table 103. APAC Peptides Sales Quantity by Region (2024-2034) & (K Pcs)
Table 104. Middle East, Africa and Latin America Peptides Sales Quantity by Company (2018-2024) & (K Pcs)
Table 105. Middle East, Africa and Latin America Peptides Revenue by Company (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Peptides Sales Quantity by Type (2018-2024) & (K Pcs)
Table 107. Middle East, Africa and Latin America Peptides Sales Quantity by Type (2024-2034) & (K Pcs)
Table 108. Middle East, Africa and Latin America Peptides Revenue by Type (2018-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Peptides Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Peptides Sales Quantity by Application (2018-2024) & (K Pcs)
Table 111. Middle East, Africa and Latin America Peptides Sales Quantity by Application (2024-2034) & (K Pcs)
Table 112. Middle East, Africa and Latin America Peptides Revenue by Application (2018-2024) & (US$ Million)
Table 113. Middle East, Africa and Latin America Peptides Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Peptides Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Peptides Revenue by Country (2018-2024) & (US$ Million)
Table 116. Middle East, Africa and Latin America Peptides Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Peptides Sales Quantity by Country (2018-2024) & (K Pcs)
Table 118. Middle East, Africa and Latin America Peptides Sales Quantity by Country (2024-2034) & (K Pcs)
Table 119. Cipla Ltd. Company Information
Table 120. Cipla Ltd. Description and Overview
Table 121. Cipla Ltd. Peptides Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 122. Cipla Ltd. Peptides Product and Services
Table 123. Cipla Ltd. Peptides SWOT Analysis
Table 124. Cipla Ltd. Recent Developments
Table 125. Emcure Pharmaceuticals Pvt. Ltd. Company Information
Table 126. Emcure Pharmaceuticals Pvt. Ltd. Description and Overview
Table 127. Emcure Pharmaceuticals Pvt. Ltd. Peptides Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Emcure Pharmaceuticals Pvt. Ltd. Peptides Product and Services
Table 129. Emcure Pharmaceuticals Pvt. Ltd. Peptides SWOT Analysis
Table 130. Emcure Pharmaceuticals Pvt. Ltd. Recent Developments
Table 131. Gland Pharma Limited Company Information
Table 132. Gland Pharma Limited Description and Overview
Table 133. Gland Pharma Limited Peptides Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 134. Gland Pharma Limited Peptides Product and Services
Table 135. Gland Pharma Limited Peptides SWOT Analysis
Table 136. Gland Pharma Limited Recent Developments
Table 137. Troikaa Pharmaceuticals Ltd. Company Information
Table 138. Troikaa Pharmaceuticals Ltd. Description and Overview
Table 139. Troikaa Pharmaceuticals Ltd. Peptides Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 140. Troikaa Pharmaceuticals Ltd. Peptides Product and Services
Table 141. Troikaa Pharmaceuticals Ltd. Peptides SWOT Analysis
Table 142. Troikaa Pharmaceuticals Ltd. Recent Developments
Table 143. Biological E Limited Company Information
Table 144. Biological E Limited Description and Overview
Table 145. Biological E Limited Peptides Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 146. Biological E Limited Peptides Product and Services
Table 147. Biological E Limited Peptides SWOT Analysis
Table 148. Biological E Limited Recent Developments
Table 149. Bharat Biotech Company Information
Table 150. Bharat Biotech Description and Overview
Table 151. Bharat Biotech Peptides Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 152. Bharat Biotech Peptides Product and Services
Table 153. Bharat Biotech Peptides SWOT Analysis
Table 154. Bharat Biotech Recent Developments
Table 155. Samarth Life Sciences Pvt. Ltd. Company Information
Table 156. Samarth Life Sciences Pvt. Ltd. Description and Overview
Table 157. Samarth Life Sciences Pvt. Ltd. Peptides Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 158. Samarth Life Sciences Pvt. Ltd. Peptides Product and Services
Table 159. Samarth Life Sciences Pvt. Ltd. Peptides SWOT Analysis
Table 160. Samarth Life Sciences Pvt. Ltd. Recent Developments
Table 161. VHB Life Sciences Limited Company Information
Table 162. VHB Life Sciences Limited Description and Overview
Table 163. VHB Life Sciences Limited Peptides Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 164. VHB Life Sciences Limited Peptides Product and Services
Table 165. VHB Life Sciences Limited Peptides SWOT Analysis
Table 166. VHB Life Sciences Limited Recent Developments
Table 167. Celon Laboratories Pvt. Ltd. Company Information
Table 168. Celon Laboratories Pvt. Ltd. Description and Overview
Table 169. Celon Laboratories Pvt. Ltd. Peptides Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 170. Celon Laboratories Pvt. Ltd. Peptides Product and Services
Table 171. Celon Laboratories Pvt. Ltd. Peptides SWOT Analysis
Table 172. Celon Laboratories Pvt. Ltd. Recent Developments
Table 173. United Biotech(P) Limited Company Information
Table 174. United Biotech(P) Limited Description and Overview
Table 175. United Biotech(P) Limited Peptides Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 176. United Biotech(P) Limited Peptides Product and Services
Table 177. United Biotech(P) Limited Peptides SWOT Analysis
Table 178. United Biotech(P) Limited Recent Developments
Table 179. Key Raw Materials Lists
Table 180. Raw Materials Key Suppliers Lists
Table 181. Peptides Distributors List
Table 182. Peptides Customers List
Table 183. Peptides Market Trends
Table 184. Peptides Market Drivers
Table 185. Peptides Market Challenges
Table 186. Peptides Market Restraints
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptides Product Picture
Figure 2. Global Peptides Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Peptides Market Share by Type in 2022 & 2034
Figure 4. Insulin Product Picture
Figure 5. Teriparatide Product Picture
Figure 6. Liraglutide Product Picture
Figure 7. Leuprolide Product Picture
Figure 8. Global Peptides Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global Peptides Market Share by Application in 2022 & 2034
Figure 10. Diabetes
Figure 11. Infectious Diseases
Figure 12. Cancer
Figure 13. Osteoporosis
Figure 14. Peptides Report Years Considered
Figure 15. Global Peptides Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 16. Global Peptides Revenue 2018-2034 (US$ Million)
Figure 17. Global Peptides Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 18. Global Peptides Sales Quantity 2018-2034 (K Pcs)
Figure 19. Global Peptides Sales Quantity Market Share by Region (2018-2024)
Figure 20. Global Peptides Sales Quantity Market Share by Region (2024-2034)
Figure 21. North America Peptides Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 22. North America Peptides Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Europe Peptides Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 24. Europe Peptides Revenue YoY (2018-2034) & (US$ Million)
Figure 25. China Peptides Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 26. China Peptides Revenue YoY (2018-2034) & (US$ Million)
Figure 27. APAC Peptides Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 28. APAC Peptides Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Peptides Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 30. Middle East, Africa and Latin America Peptides Revenue YoY (2018-2034) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by Peptides Sales Quantity in 2022
Figure 32. The Top 10 and Top 5 Players Market Share by Peptides Revenue in 2022
Figure 33. Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Peptides Sales Quantity Market Share by Type (2018-2034)
Figure 35. Global Peptides Revenue Market Share by Type (2018-2034)
Figure 36. Global Peptides Sales Quantity Market Share by Application (2018-2034)
Figure 37. Global Peptides Revenue Market Share by Application (2018-2034)
Figure 38. North America Peptides Revenue Market Share by Company in 2022
Figure 39. North America Peptides Sales Quantity Market Share by Company in 2022
Figure 40. North America Peptides Sales Quantity Market Share by Type (2018-2034)
Figure 41. North America Peptides Revenue Market Share by Type (2018-2034)
Figure 42. North America Peptides Sales Quantity Market Share by Application (2018-2034)
Figure 43. North America Peptides Revenue Market Share by Application (2018-2034)
Figure 44. North America Peptides Revenue Share by Country (2018-2034)
Figure 45. North America Peptides Sales Quantity Share by Country (2018-2034)
Figure 46. U.S. Peptides Revenue (2018-2034) & (US$ Million)
Figure 47. Canada Peptides Revenue (2018-2034) & (US$ Million)
Figure 48. Europe Peptides Sales Quantity Market Share by Company in 2022
Figure 49. Europe Peptides Revenue Market Share by Company in 2022
Figure 50. Europe Peptides Sales Quantity Market Share by Type (2018-2034)
Figure 51. Europe Peptides Revenue Market Share by Type (2018-2034)
Figure 52. Europe Peptides Sales Quantity Market Share by Application (2018-2034)
Figure 53. Europe Peptides Revenue Market Share by Application (2018-2034)
Figure 54. Europe Peptides Revenue Share by Country (2018-2034)
Figure 55. Europe Peptides Sales Quantity Share by Country (2018-2034)
Figure 56. Germany Peptides Revenue (2018-2034) & (US$ Million)
Figure 57. France Peptides Revenue (2018-2034) & (US$ Million)
Figure 58. U.K. Peptides Revenue (2018-2034) & (US$ Million)
Figure 59. Italy Peptides Revenue (2018-2034) & (US$ Million)
Figure 60. Russia Peptides Revenue (2018-2034) & (US$ Million)
Figure 61. China Peptides Sales Quantity Market Share by Company in 2022
Figure 62. China Peptides Revenue Market Share by Company in 2022
Figure 63. China Peptides Sales Quantity Market Share by Type (2018-2034)
Figure 64. China Peptides Revenue Market Share by Type (2018-2034)
Figure 65. China Peptides Sales Quantity Market Share by Application (2018-2034)
Figure 66. China Peptides Revenue Market Share by Application (2018-2034)
Figure 67. APAC Peptides Sales Quantity Market Share by Company in 2022
Figure 68. APAC Peptides Revenue Market Share by Company in 2022
Figure 69. APAC Peptides Sales Quantity Market Share by Type (2018-2034)
Figure 70. APAC Peptides Revenue Market Share by Type (2018-2034)
Figure 71. APAC Peptides Sales Quantity Market Share by Application (2018-2034)
Figure 72. APAC Peptides Revenue Market Share by Application (2018-2034)
Figure 73. APAC Peptides Revenue Share by Region (2018-2034)
Figure 74. APAC Peptides Sales Quantity Share by Region (2018-2034)
Figure 75. Japan Peptides Revenue (2018-2034) & (US$ Million)
Figure 76. South Korea Peptides Revenue (2018-2034) & (US$ Million)
Figure 77. China Taiwan Peptides Revenue (2018-2034) & (US$ Million)
Figure 78. Southeast Asia Peptides Revenue (2018-2034) & (US$ Million)
Figure 79. India Peptides Revenue (2018-2034) & (US$ Million)
Figure 80. Middle East, Africa and Latin America Peptides Sales Quantity Market Share by Company in 2022
Figure 81. Middle East, Africa and Latin America Peptides Revenue Market Share by Company in 2022
Figure 82. Middle East, Africa and Latin America Peptides Sales Quantity Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Peptides Revenue Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Peptides Sales Quantity Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Peptides Revenue Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Peptides Sales Quantity Share by Country (2018-2034)
Figure 87. Middle East, Africa and Latin America Peptides Revenue Share by Country (2018-2034)
Figure 88. Brazil Peptides Revenue (2018-2034) & (US$ Million)
Figure 89. Mexico Peptides Revenue (2018-2034) & (US$ Million)
Figure 90. Turkey Peptides Revenue (2018-2034) & (US$ Million)
Figure 91. Israel Peptides Revenue (2018-2034) & (US$ Million)
Figure 92. GCC Countries Peptides Revenue (2018-2034) & (US$ Million)
Figure 93. Peptides Value Chain
Figure 94. Peptides Production Process
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries